|
Denali news
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 28, 2019 10:07AM
|
|
Re: AACR 2019
|
3
|
Zenith Epigenetics
|
Feb 28, 2019 08:33AM
|
|
Re: Upcoming Zenith Events
|
2
|
Zenith Epigenetics
|
Feb 27, 2019 10:50PM
|
|
AACR 2019
|
4
|
Zenith Epigenetics
|
Feb 27, 2019 10:45PM
|
|
Re: Mark Day interview with Stock News Now
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 27, 2019 06:49PM
|
|
Re: When to expect the 250th Event
|
9
|
Resverlogix Corp.
|
Feb 27, 2019 05:41PM
|
|
Mark Day interview with Stock News Now
|
4
|
BIOASIS TECHNOLOGIES INC
|
Feb 27, 2019 01:53PM
|
|
FSHD and apabetalone topical formulation
|
6
|
Resverlogix Corp.
|
Feb 27, 2019 01:36PM
|
|
The Faces of Cardiovascular Disease: Part 2
|
3
|
Resverlogix Corp.
|
Feb 26, 2019 07:46PM
|
|
Re: Zacks SCR Resverlogix Report 12/28/18
|
3
|
Resverlogix Corp.
|
Feb 26, 2019 07:39PM
|
|
Re: When to expect the 250th Event
|
2
|
Resverlogix Corp.
|
Feb 26, 2019 07:30PM
|
|
Re: Zacks SCR Resverlogix Report 12/28/18
|
4
|
Resverlogix Corp.
|
Feb 26, 2019 10:06AM
|
|
Re: EAS tweet
|
3
|
Resverlogix Corp.
|
Feb 25, 2019 12:13PM
|
|
EAS tweet
|
7
|
Resverlogix Corp.
|
Feb 25, 2019 11:48AM
|
|
Voyager, AAVs and Gene Targeted Therapies
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 24, 2019 03:48PM
|
|
Re: Sparks Therapeutics Gene Therapy Deal
|
5
|
Resverlogix Corp.
|
Feb 24, 2019 03:23PM
|
|
Re: Sparks Therapeutics Gene Therapy Deal
|
4
|
Resverlogix Corp.
|
Feb 24, 2019 09:51AM
|
|
Re: Sparks Therapeutics Gene Therapy Deal
|
2
|
Resverlogix Corp.
|
Feb 24, 2019 07:23AM
|
|
Re: Apabetalone's impact on blood pressure
|
2
|
Resverlogix Corp.
|
Feb 23, 2019 04:53PM
|
|
Re: BETonMACE Enrollment
|
5
|
Resverlogix Corp.
|
Feb 23, 2019 02:33PM
|
